Wound Healing News and Research RSS Feed - Wound Healing News and Research

Lilly receives fourth FDA approval for CYRAMZA (ramucirumab)

Lilly receives fourth FDA approval for CYRAMZA (ramucirumab)

Eli Lilly and Company has received its fourth U.S. Food and Drug Administration approval for CYRAMZA (ramucirumab). CYRAMZA (ramucirumab injection 10 mg/mL solution) is now also indicated in combination with FOLFIRI (irinotecan, folinic acid, and 5-fluorouracil) chemotherapy for the treatment of patients with metastatic colorectal cancer (mCRC) with disease progression on or after prior therapy with bevacizumab, oxaliplatin, and a fluoropyrimidine. [More]
New ACS initiative aims to improve outcomes for patients who require complex wound management

New ACS initiative aims to improve outcomes for patients who require complex wound management

The American College of Surgeons today announced a new initiative to improve outcomes for patients requiring complex wound management. ACS will release a new structured teaching and verification program that utilizes engaging media and self-assessment checklists to educate surgical patients and their families about delivering self-care for wound conditions. [More]
Ancient natural compound can protect the heart from hypertrophy

Ancient natural compound can protect the heart from hypertrophy

A natural compound derived from the bark of the magnolia tree, can protect the heart from hypertrophy, a thickening of cardiac muscle often caused by chronic high blood pressure that can lead to heart failure, researchers report in the April 14 issue of the online journal Nature Communications. [More]
Amniotic stem cells promote growth of functional blood vessels in healing hydrogels

Amniotic stem cells promote growth of functional blood vessels in healing hydrogels

Rice University and Texas Children's Hospital scientists are using stem cells from amniotic fluid to promote the growth of robust, functional blood vessels in healing hydrogels. [More]
Researchers test effects of light therapy on brain function

Researchers test effects of light therapy on brain function

Following up on promising results from pilot work, researchers at the VA Boston Healthcare System are testing the effects of light therapy on brain function in veterans with Gulf War Illness. [More]
Treating common gum disease in CKD patients could reduce heart disease risk

Treating common gum disease in CKD patients could reduce heart disease risk

Treating a common gum condition in chronic kidney disease (CKD) patients could significantly reduce their risk of potentially fatal heart disease, Aston University researchers say. [More]
Experimental nanoparticle therapy speeds healing of all sorts of wounds

Experimental nanoparticle therapy speeds healing of all sorts of wounds

An experimental therapy developed by researchers at Albert Einstein College of Medicine of Yeshiva University cut in half the time it takes to heal wounds compared to no treatment at all. Details of the therapy, which was successfully tested in mice, were published online in the Journal of Investigative Dermatology. [More]
TxCell to present at upcoming US and French investment conferences

TxCell to present at upcoming US and French investment conferences

Damian Marron, CEO, TxCell, will present at the Alliance for Regenerative Medicine's 3rd Annual Regen Med Investor Day, New York, March 25, 2015. In addition, Damian Marron will also participate at the Portzamparc PEA-PME Forum, Paris, April 1, 2015. [More]
Study sheds light on cell migration mechanisms involved in wound-healing process

Study sheds light on cell migration mechanisms involved in wound-healing process

Researchers at the University of Arizona have discovered what causes and regulates collective cell migration, one of the most universal but least understood biological processes in all living organisms. [More]
Novel drug mechanism shows promise against glioma cells

Novel drug mechanism shows promise against glioma cells

Researchers at UC Davis have developed and characterized a molecule that interferes with the internal regulation of cancer cells, causing them to self-destruct. This novel mechanism was found to be effective against glioma cells - responsible for a usually fatal type of brain cancer - and could be applicable to other highly aggressive cancers. [More]
Novel technology could improve diagnosis of peripheral arterial disease

Novel technology could improve diagnosis of peripheral arterial disease

Approximately 8 to 12 million people in the United States alone are suffering from peripheral arterial disease (PAD), a common vascular problem that is caused by narrowing of the arteries as a result of plaque buildup. The plaque accumulation leads to an insufficient blood flow to the body's extremities and increases a person's risk for heart attack and stroke by up to six times. PAD is also one of the most serious complications of diabetes. [More]
Nuo Therapeutics initiates phase 4 study of Aurix™ under CMS coverage with evidence development program

Nuo Therapeutics initiates phase 4 study of Aurix™ under CMS coverage with evidence development program

Nuo Therapeutics, Inc. (OTCQX:NUOT), a pioneer in biodynamic therapies, today announced the initiation of a new clinical study (Au Study) that is comprised of three randomized controlled protocols that examine the efficacy of Aurix™, a biodynamic hematogel, for use in diabetic foot ulcers, venous leg ulcers and pressure ulcers (bed sores). [More]
Researchers develop durable antibacterial coatings of nanocomposites

Researchers develop durable antibacterial coatings of nanocomposites

Ruthless with bacteria, harmless to human cells. New, durable antibacterial coatings of nanocomposites, developed at the Institute of Physical Chemistry of the Polish Academy of Sciences in Warsaw, will in future help to improve the hygiene of sportswear, and used in medicine, will reduce the rate of infections and shorten the times of in-patient hospital admissions. [More]
Researchers report development of first 3D tissue-engineered system

Researchers report development of first 3D tissue-engineered system

A team led by researchers at Tufts University School of Engineering and the University of Pavia has reported development of the first three-dimensional tissue system that reproduces the complex structure and physiology of human bone marrow and successfully generates functional human platelets. [More]
Mass General's D. Dante Yeh named recipient of A.S.P.E.N.'s Promising Investigator Award

Mass General's D. Dante Yeh named recipient of A.S.P.E.N.'s Promising Investigator Award

D. Dante Yeh, MD, of Massachusetts General Hospital has been named the Promising Investigator Award recipient by the American Society for Parenteral and Enteral Nutrition. The award is for his research on improving nutritional delivery to intensive care unit (ICU) patients, which was presented at A.S.P.E.N.'s Clinical Nutrition Week conference in Long Beach, California, February 14 to 17. [More]
Discovery leads to new understanding of cancer metastasis

Discovery leads to new understanding of cancer metastasis

In a breakthrough in the understanding of how cancer spreads, researchers at the University of Virginia School of Medicine have identified a substance secreted by lung cancer cells that enables them to metastasize, beginning their deadly march to other sites in the body. [More]
Lintec to commercialize carbon nanotubes developed at UTD

Lintec to commercialize carbon nanotubes developed at UTD

Lintec of America recently announced an exclusive license to commercialize novel fabrication methods for carbon nanotube (CNT) macrostructures, including sheets, yarns and ribbons, developed at the University of Texas at Dallas. [More]
Study reveals mechanical forces that drive epithelial wound healing

Study reveals mechanical forces that drive epithelial wound healing

A collaborative study led by scientists from the Mechanobiology Institute at the National University of Singapore has revealed the mechanical forces that drive epithelial wound healing in the absence of cell supporting environment. This research was published in Nature Communications in January 2015. [More]
Loyola orthopaedic surgeon uses new minimally invasive technique to repair ruptured Achilles tendon

Loyola orthopaedic surgeon uses new minimally invasive technique to repair ruptured Achilles tendon

Orthopaedic surgeon Adam Schiff, MD, of Loyola University Medical Center, used a new minimally invasive technique to repair the ruptured Achilles tendon on Mr. Frias' left leg. The technique requires a smaller incision, minimizes wound healing complications and leaves less scar tissue. [More]
Virginia Hospital Center joins Mayo Clinic Care Network

Virginia Hospital Center joins Mayo Clinic Care Network

Mayo Clinic and Virginia Hospital Center today announced Virginia Hospital Center as a member of the Mayo Clinic Care Network, a national network of organizations committed to better serving patients and their families through collaboration. Members of the network have access to Mayo Clinic knowledge and expertise to give their patients additional peace of mind when making health care decisions while continuing to offer the highest quality and value of care close to home. [More]
Advertisement